Stanford to test antiviral pills as long COVID treatment
By
Alicia Lasek
Nov 28, 2022
Investigators plan to test whether the antiviral drug Paxlovid will relieve symptoms of the syndrome known as long COVID, also called post-acute sequelae of COVID-19.
New treatment, prevention toolkit for clinicians addresses ‘tripledemic’
By
Alicia Lasek
Nov 15, 2022
Five medical societies have created a toolkit designed to help clinicians increase the effectiveness, accessibility and awareness of oral antiviral therapeutics and COVID-19 booster vaccines.
NIH: COVID rebound after Paxlovid may signal a strong immune response
By
Alicia Lasek
Oct 11, 2022
Patients who had rebound symptoms after taking Paxlovid showed a more robust immune response to SARS-CoV-2 than patients with no rebound, investigators reported.
Clinical briefs for Thursday, Sept. 8
By
Alicia Lasek
Sep 08, 2022
Pfizer’s COVID pill Paxlovid has profound effect in seniors, NEJM study finds … SNFs can access free COVID testing for staff, residents through Dec. 31 … Researchers identify risk of COVID and its...
Oral antivirals most effective for COVID patients with milder disease, study authors contend
By
Alicia Lasek (f3)
Jul 27, 2022
Molnupiravir and Paxlovid appear to reduce the risk of death and hospital admission without increasing adverse events in patients with mild-to-moderate COVID-19, a sweeping review of studies has found.
Doctors seek more prescribing guidance on Paxlovid
By
Liza Berger
Jul 12, 2022
As access to Pfizer’s Paxlovid pill widens, doctors remain concerned about how to prescribe it for high-risk patients.
Also in the News for Monday, July 11
By
Kimberly Marselas
Jul 11, 2022
Nursing and residential care facilities gained 8,000 jobs in June: BLS report …Pharmacists now allowed to give Paxlovid for COVID, but how much should they get paid, and how many seniors would have adverse...
SARS-CoV-2-linked hospitalization, ED encounters rare after Paxlovid
Jun 28, 2022
As an early-stage treatment, Paxlovid may prevent COVID-19-related hospitalization among patients with mild-to-moderate COVID-19 cases, investigators say.
COVID antiviral study raises red flag for mental status changes in nursing home residents
By
Alicia Lasek (f3)
Jun 28, 2022
Nursing home residents who took COVID antiviral pills had a low hospitalization rate, but some experienced mental status changes while taking Paxlovid, a unique call center study has found.
Paxlovid doesn’t cut hospitalization, death in ‘standard-risk’ patients, Pfizer says
By
Alicia Lasek (f3)
Jun 16, 2022
The oral antiviral pill Paxlovid does not significantly reduce the risk of severe COVID-19 in patients at “standard risk” of poor outcomes, the drug’s maker reports.